These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11981074)

  • 1. 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis.
    Buccianti G; Raselli S; Baragetti I; Bamonti F; Corghi E; Novembrino C; Patrosso C; Maggi FM; Catapano AL
    Nephrol Dial Transplant; 2002 May; 17(5):857-64. PubMed ID: 11981074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration.
    Baragetti I; Raselli S; Stucchi A; Terraneo V; Furiani S; Buzzi L; Garlaschelli K; Alberghini E; Catapano AL; Buccianti G
    Nephrol Dial Transplant; 2007 Nov; 22(11):3292-7. PubMed ID: 17595187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B(12) in uraemic patients on maintenance haemodialysis.
    Buccianti G; Bamonti Catena F; Patrosso C; Corghi E; Novembrino C; Baragetti I; Lando G; De Franceschi M; Maiolo AT
    Am J Nephrol; 2001; 21(4):294-9. PubMed ID: 11509801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study.
    Spijkerman AM; Smulders YM; Kostense PJ; Henry RM; Becker A; Teerlink T; Jakobs C; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):778-84. PubMed ID: 15692102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Baarholm OA; Van-Assche T; Cunnington C; Pillai R; Ratnatunga C; Tousoulis D; Stefanadis C; Refsum H; Channon KM
    Circulation; 2009 May; 119(18):2507-15. PubMed ID: 19398669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?
    Doshi SN; McDowell IF; Moat SJ; Lang D; Newcombe RG; Kredan MB; Lewis MJ; Goodfellow J
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1196-202. PubMed ID: 11451751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
    Thambyrajah J; Landray MJ; McGlynn FJ; Jones HJ; Wheeler DC; Townend JN
    Circulation; 2000 Aug; 102(8):871-5. PubMed ID: 10952955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.
    Dinckal MH; Aksoy N; Aksoy M; Davutoglu V; Soydinc S; Kirilmaz A; Dinckal N; Akdemir I
    Acta Cardiol; 2003 Oct; 58(5):389-96. PubMed ID: 14609303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate improves endothelial function in patients with coronary heart disease.
    Doshi S; McDowell I; Moat S; Lewis M; Goodfellow J
    Clin Chem Lab Med; 2003 Nov; 41(11):1505-12. PubMed ID: 14656033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Vitamin B12 Deficiency with Homozygosity of the TT MTHFR C677T Genotype, Hyperhomocysteinemia, and Endothelial Cell Dysfunction.
    Shiran A; Remer E; Asmer I; Karkabi B; Zittan E; Cassel A; Barak M; Rozenberg O; Karkabi K; Flugelman MY
    Isr Med Assoc J; 2015 May; 17(5):288-92. PubMed ID: 26137654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina.
    Guo H; Chi J; Xing Y; Wang P
    Indian J Med Res; 2009 Mar; 129(3):279-84. PubMed ID: 19491420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
    Verhaar MC; Wever RM; Kastelein JJ; van Dam T; Koomans HA; Rabelink TJ
    Circulation; 1998 Jan; 97(3):237-41. PubMed ID: 9462523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.
    Title LM; Ur E; Giddens K; McQueen MJ; Nassar BA
    Vasc Med; 2006 May; 11(2):101-9. PubMed ID: 16886840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
    Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y
    Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients.
    van Guldener C; Janssen MJ; Lambert J; ter Wee PM; Jakobs C; Donker AJ; Stehouwer CD
    Nephrol Dial Transplant; 1998 Jan; 13(1):106-12. PubMed ID: 9481724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women.
    Fohr IP; Prinz-Langenohl R; Brönstrup A; Bohlmann AM; Nau H; Berthold HK; Pietrzik K
    Am J Clin Nutr; 2002 Feb; 75(2):275-82. PubMed ID: 11815318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.